Upsala J Med Sci 92: 19-35, 1987 Some Effects of Metolazone on Electrolyte Transport Bo Odlind,’ Bjorn Beermann,’ Bjorn Lindstrom,3 and Orjan Eriksson’ ‘Departments of Medicine, University Hospiial, U p p s a l a , ’S:t Eriks Hospital, Stockholm and ’Department of Drugs, National Board of Health and W e y a r e , Uppsala, Sweden ABSTRACT Metolazone a c t i o n was s t u d i e d 1) i n v i t r o on i s o l a t e d operculum of F u n d u l u s h e t e r o c l i t u s ( a c t i v e c h l o r i d e t r a n s p o r t ) using an Ussinq chamber ( m e t o l a z o n e c o n c 500 pM) and i n v i v o 2 ) u s i n g t h e modified Sperber t e c h n i q u e i n t h e hen (metolazone i n f u s i o n r a t e 0.75-1.2 p g / k g / m i n ) and 3 ) i n h e a l t h y v o l u n t e e r s u s i n g c l e a r a n c e t e c h n i q u e s (metolazone i n f u s i o n r a t e 10 mg/h). 1 ) Metolazone reduced ( p < 0 . 0 5 ) s h o r t c i r c u i t c u r r e n t and p o t e n t i a l d i f f e r e n c e s w i t h 20% from a v e r a g e c o n t r o l v a l u e s ( p < O . O 5 ) , w h i l e d i r e c t c u r r e n t r e s i s t a n c e was unchanged. This i s comparable t o t h i a z i d e b u t much l o w e r t h a n l o o p d i u r e t i c e f f e c t s . 2 ) T r u e t u b u l a r e x c r e t i o n f r a c t i o n of metolazone before and a f t e r novobiocin ( 2 . 7 pnol/kq/rnin c o i n f u s i o n averaqed 14.1 and 4.5 %, r e s p . (o 0 . 0 5 ) when a d m i n i s t e r e d t o t h e s e r o s a l a n d mucosal s i d e , r e s p e c t i v e l y , o f t o a d u r i n a r y b l a d d e r ( T a b l e I ) . T a b l e I. E f f e c t s o f m e t o l a z o n e on t h e p o t e n t i a l d i f f e r e n c e (PD), s h o r t c i r - c u i t c u r r e n t (SCC) and d i r e c t c u r r e n t r e s i s t a n c e ( R ) i n i s o l a t e d o p e r c u l a r e p i t h e 1 i a o f Fundul u s h e t e r o c l i t u s and i n i s o l a t e d t o a d b l a d d e r .The d r u g ( 5 0 0 pM) was added t o t h e s e r o s a l ( S ) o r mucosal (M) s i d e o f t h e e p i t h e l i u m . The e l e c t r i c a l p a r a m e t e r s w e r e r e c o r d e d b e f o r e a n d o n e h o u r a f t e r m e t o l a z o n e exposure. R e s u l t s a r e g i v e n a s p e r c e n t change from c o n t r o l v a l u e s . The number o f e p i t h e l i a t e s t e d a r e g i v e n w i t h i n p a r e n t h e s e s ( x d e n o t e s p<0.05). PD SCC R % change f r o m c o n t r o l . O p e r c u l a r e p i t h e l i u m S ( 4 ) -20.6 - + 2.8' -19.5 - + 4.5' -0.1 - + 8.7 S ( 4 ) -0.4 + 6 . 2 -14.2 + 7.1 +18.0 + 11.0 - - - U r i n a r y b l adder M ( 4 ) + 6 . 4 + 4.9 +15.8 + 5.5 -5.8 + 8.2 - - - U r i n a r y b l a d d e r , 23 The modified Sperber technique. A t s t e a d y s t a t e t h e TTEFM value of CI4 metolazone averaqed 14.1 - + 4.2 % ( c a l c u l a t e d a s means of 4-5 c o l l e c t i o n p e r i o d s of 1 0 min from e a c h of 8 a n i m a l s ) . A f t e r a new steady s t a t e had been reached during novobiocin c o i n f u - s i o n , t h i s v a l u e was s i q n i f i c a n t l y ( p < 0 . 0 0 1 ) r e d u c e d t o 4 . 5 2 2 . 0 % ( c a l c u l a t e d a s means from 3 - ( 4 ) c o l l e c t i o n p e r i o d s of 10 min from each of 8 a n i m a l s ) . Corresponding r e s u l t s f o r t o t a l ( i n j e c t i o n s i d e p l u s c o n t r o l s i d e ) u r i n a r y e x c r e t i o n was 58.8 - + 6.0% and 37.7 - + 2.9% ( p < 0.001), o f t h e i n f u s e d amount, r e s p e c t i v e l y . The u r i n a r y e x c r e t i o n r a t e of c h l o r i d e , sodium and w e r e s y m m e t r i c a l t h o u q h o u t a l l p o t a s s i u m a s w e l l a s C E D T A a n d C experiments. ( c f . Fig 1). Hi P P F:g 1. Typical r e s u l t s from one experiment with t h e modified Sperber technique. I n f u s i o n r a t e o f ~ 1 4 metolazone was 0 . 9 pg/kg/min. The t r u e t u b u l a r ex- c r e t i o n f r a c t i o n o f metolazone ( T T E F M ) , sodium, c h l o r i d e and p o t a s s i u excretion I"5-Na-0-iodohippurate from i n j e c t ion and c o n t r o l kidneys, r e s p e c t i v e l y , a r e shown. a t h e renal c l e a r a n c e s of Cr Y IEDTA a n d .. C - 0 - 3 0 - 2 O - - l O 0-10 20-30 LO-SO COLLECTION PERIOD (min) Clearance s t u d i e s i n heal thy v o l u n t e e r s . The plasma l e v e l s of m e t o l a z o n e were s l o w l y i n c r e a s i n g a t t h e t i m e o f i n j e c t i o n of p r o b e n e c i d when they averaged 402 2 64 n q / m l ( F i g 21. The renal c l e a r a n c e of metolazone ( F i g 2 ) was almost i d e n t i c a l d u r i n q t h e two p e r i o d s b e f o r e probenecid a d m i n i s t r a t i o n ( p e r i o d s - 2 a n d -1) when i t averaged 184 - + 25 a n d 173 - + 20 m l / m i n , r e s p e c t i v e l y . Accordingly, period -1 was c h o s e n as con- t r o l p e r i o d . The i n j e c t i o n o f probenecid caused a decrease i p renal c l e a r a n c e o f metolazone t o 33 - + 7 ml/min, which corresponds t o 18 - + 2.8 per c e n t o f t h e 24 c l e a r a n c e d u r i n g p e r i o d -1. The d e c l i n e i n c l e a r a n c e was followed by a con- t i n u o u s r i s e i n plasma l e v e l s of metolazone u p t o 930 2 204 ng/ml a t 3 h a f t e r t h e a d m i n i s t r a t i o n o f probenecid ( F i g 2 ) . 1000 - E 2 500- 1 - * * * * * * * * 1 IJ' f ' J ' - 2 ' - 1 ' 1 2 ' 3 ' 4 ' 5 ' 6 ' Perlod P Fig 2 . .' 150- E I E 100- 50 - C M 2501 200 U M 100, * * * I * * T * * * * * * T T Plasma l e v e l s ( S I ~ ) , renal c l e a r - ance (CM) a n d u r i n a r y e x c r e t i o n ( U M ) of metolazone during i n t r a - venous i n f u s i o n of metolazone b e f o r e and a f t e r i n j e c t i o n of probenecid ( P ) . * p<0.05 in com- parison t o c o n t r o l period (hatched a r e a ) . 25 The u r i n a r y f l o w d u r i n g t h e p e r i o d p r e c e e d i n q t h e i n j e c t i o n o f p r o b e n e c i d was 4 . 1 - + 0.6 m l / m i n i n mean ( F i g 3 ) . The i n j e c t i o n o f p r o b e n e c i d c a u s e d a s l i g h t b u t i n s i g n i f i c a n t decrease i n d i u r e s i s w h i c h was f o l l o w e d b y a s i g - n i f i c a n t mean i n c r e a s e ( p < 0.05) i n e x c r e t i o n o f u r i n e , d u r i n g p e r i o d 3 and 4 when t h e d i u r e s i s averaged 5.3 1.3 (131.4 2 32.4 p e r c e n t o f c o n t r o l ) a n d 4.9 - + 1.6 ( 1 2 0 . 3 - + 1 1 . 0 p e r c e n t ) m l / m i n , r e s p e c t i v e l y . The response t o t h e i n j e c t i o n o f p r o b e n e c i d w i t h r e g a r d s t o t i m e f o r maximal c h a n g e d i f f e r e d be- t w e e n i n d i v i d u a l s . Thus, t h e maximal i n d i v i d u a l i n c r e a s e i n d i u r e s i s averaged 155.9 + 15.4 Der c e n t o f c o n t r o l d i u r e s i s ( p < 0.001). * * m - 1 1 2 3 4 5 P * * 1 6 Period F i g 3 a,b. U r i n a r y o u t p u t o f w a t e r ( U H ~ O ) c h l o r i d e ( U c i - ) , sodium (Uva+) and p o t a s s i u m ( U K + ) d u r i n g i n t r a v e n o u s i n f u s i o n o f m e t o l a z o n e b e f o r e and a f t e r i n j e c t i o n o f p r o b e n e c i d ( P ) . * p < 0 . 0 5 i n comparison t o c o n t r o l p e r i o d ( h a t c h e d a r e a ) . * * * m - 1 1 2 3 4 5 8 KE - 1 1 2 3 m + 1 4 5 6 Period 1 6 Period 1 6 Period 26 GFR was 1 1 2 - + 1 4 ml/min d u r i n g t h e period b e f o r e t h e i n j e c t i o n of metolazone. I t did not d i f f e r from t h a t during t h e c o n t r o l p e r i o d when i t averaged 1 0 9 - + 13 rnl/min. Probenecid caused a s i g n i f i c a n t increase in GFR during periods 3 ( 1 2 3 5 1 6 ml/min) and 4 (114 - + 9 ml/min). This increase could a t l e a s t i n part explain the increased d i u r e s i s during those periods, as cor- responding mean fractional excretion of water ( E F ) ( 4 . 5 2 1.4 a n d 4.3 - + 1.3 per cent, respectively) did n o t d i f f e r s i g n i f i c a n t l y from t h a t during the con- t r o l period (3.8 + 0.5 per c e n t ) . However, the maximal individual EF ( 6 . 1 - + 0.6 per cent; period 4.7 - + 1) corresponded t o 163.3 - + 25.7 per cent of control ( p < 0,001). ( F i g 4 ) . "2O H2° - EF per cent H20 K ' Na' CI- I" * * * * * I * Na+ CI - H P Fig 4. Maximal change ( u n f i l l e d a r e a ) in fractional ex- c r e t i o n ( E F ) o f water, sodium, chloride and potas- sium during intravenous infusion of metolazone before and a f t e r injection of probenecid. ** p